Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 352 | 0 | N/A | 0 | 0 |
| TOTAL | $550 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,181 | 0 | 0 | 0 | 0 |
| TOTAL | $1,181 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,731 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,893 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 348 | 0 | N/A | 0 | 0 |
| TOTAL | $20,073 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 95,914 | 0 | 0 | 0 | 0 |
| TOTAL | $95,914 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $115,987 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,532 | N/A | N/A | N/A | N/A |
| Retained earnings | -119,963 | 0 | N/A | 0 | 0 |
| TOTAL | $-114,257 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $1,731 | $0 | $0 | $0 | $0 |